The approval by the US Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for ...

Marksans Pharma announced the final approval of the Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg from USFDA. They are indicated for the treatment of allergic ...

The approval by the US Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Loratadine tablets of strength 10 mg, Marksans Pharma said in a regulatory ...

Marksans Pharma Ltd has gained final USFDA approval for its generic Loratadine tablets, used to treat allergic rhinitis. This approval allows the company to market a generic version of Clartin, ...

Mumbai: Marksans Pharma Limited has announced the final approval of its Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg from the USFDA. Loratadine Tablets USP 10 mg are ...

USFDA approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

The Loratadine Tablets are used in the treatment of symptoms like itching, runny nose, watery eyes, and sneezing caused by ‘hay fever’ and other allergies.

Marksans Pharma receives USFDA approval for Loratadine Tablets USP 10 mg, expanding its generic drug portfolio.